Archives

On May 8, 2014, China's National Development and Reform Commission (NDRC) announced that retail price caps for a list of cheap, basic drugs would be relaxed, effective immediately. Instead, pharmaceutical companies will be able to set retail prices based on their costs... Read More

The Indian medical device market is worth about $4.3 billion dollars. It is expected to grow to about $12 billion dollars by 2022. More and more Western device companies are registering their products in India. For registration renewals, the DCGI is now... Read More

印度政府已经同意制药公司提出的药品最高零售价（MRPs）的请求。根据2013年印度政府药品价格管制令（DPCO），基本药物的价格涨价上限为所有药物平均增幅的1％。由于实施2013年的 药品价格管制令，基本药物的价格已经下降了40％。然而，2013年印度政府允许药物批发价格涨价6.32％。目前印度的基本药物目录包括348种原料药（650配方）。 Read More

2013年4月，我公司报道，印度中央政府保健计划（CGHS）减少了心脏医疗器械产品的报销额度-如心脏的药物洗脱支架（DES）的报销额度减少了60％。以前，美国FDA批准的心脏药物洗脱支架可以报销1,200美元。而如今只报销$460。欧盟和印度批准支架报销额度也下调到$460。 Read More

The Indian government has allowed pharmaceutical companies to raise the maximum retail prices (MRPs) for drugs. Pursuant to the Drug Price Control Order (DPCO) 2013, essential medicine prices are capped at the average increase of all drugs in a certain segment that... Read More

In April 2013, PBM noted in a newsbrief that India's Central Government Health Scheme (CGHS) had reduced its reimbursement prices for cardio products -- such as drug-eluting stents (DES) -- by up to 60%. Stents that had been approved by the U.S.... Read More

Sourcing medical devices in Asia has become a common practice as more companies are taking advantage of the lower overhead, lower labor costs and increasing technical capabilities available in the Asian countries. Medical device companies can buy and manufacture a wide array... Read More

China’s pharmaceutical market is booming! The market is growing almost 15% annually and is expected to be about $100 billion dollars in 2017. However, drug regulations are complicated in China. In addition, once your drug is approved, what needs to be done... Read More

Indonesia's pharmaceutical market is one of the fastest growing in Asia, expanding at an annual rate of 12.5 percent. It is currently worth $4.5 billion, about the same size as Taiwan's pharmaceutical market. But while Taiwan's economy is mature, Indonesia's is still... Read More

The Philippines' market for pharmaceutical products is growing at its fastest pace in years, at about 13 percent annually. By 2014, experts predict that it will have a value of $4 billion. This would make the drug market in the Philippines almost... Read More